Transcription of DECISION TREE #1: ESTABLISHING ACCEPTANCE …
{{id}} {{{paragraph}}}
Determine impurity level in relevant batches1 Determine mean + upper confidence limit for the impurity (Let this = A) ACCEPTANCE criterion = A or B(as appropriate)Isimpurity alsoa degradationproduct?IsA or B greater than thequalifiedlevel? ACCEPTANCE criterion = qualified levelor establish new qualified level2 Estimate maximum increase in impurityat retest date using data from relevantaccelerated and long-term stability studiesDetermine maximum likely level as:A + increase in degradation product atappropriate storage conditions.(Let this = B)YESYESNONODECISION tree #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE1 Relevant batches are those from development, pilot and scale-up to ICH Guideline on Impurities in New Drug SubstancesDefinition: upper confidence limit = three times the standard deviation of batch analysis dataDECISION tree #2: ESTABLISHING ACCEPTANCE CRITERION FOR A DEGRADATION PRODUCT IN A NEW DRUG PRODUCTD oesdegradationoccur during productmanufacture?
DECISION TREE #3: SETTING ACCEPTANCE CRITERIA FOR DRUG SUBSTANCE PARTICLE SIZE DISTRIBUTION Is the drug product a solid dosage form or liquid containing undissolved
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Setting Dissolution Specifications, Specifica tion, Dissolution testing, Specification, Testing, Ich harmonised tripartite guideline, Criteria, Dissolution, Dissolution Technique to Assess Generic Formulation Differences, Stability Testing of Dietary Supplements, General guidance on hold‑time studies, Quality of oral modified release, Quality of oral modified release products, Stability – Regulatory Requirements